Bright Minds (DRUG) Biosciences announced positive and significant topline results from its Phase 2 BREAKTHROUGH clinical trial evaluating BMB-101, a selective 5-HT2C biased agonist, in adult patients ...

Shares of Bright Minds Biosciences rose after the company released positive topline results from its phase two trial of a treatment for patients with drug-resistant Absence Seizures and Developmental ...

Absence: 73.1% median reduction in the number of absence seizure ≥3s, p = 0.012 DEE: 63.3% median reduction in major motor seizures REM sleep improvement in patients with Absence Seizures: mean 90% ...

Bright Minds Biosciences has debuted glowing phase 2 results for its lead anti-seizure asset, giving the biotech’s stock a jolt and setting up future registrational trials for the serotonin receptor ...

NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (DRUG) (“Bright Minds” or the “Company”), a clinical-stage biotechnology company focused on developing highly selective 5-HT ...

A long-running debate over Tamiflu’s safety in children may finally be settled. Researchers found that influenza, not the antiviral medication, was linked to serious neuropsychiatric events like ...

EXCLUSIVE: It’s now that time of the year when In Memoriam lists are being compiled and posted commemorating those who passed in 2025. For New York Times readers picking up the paper today, amidst ...

A new study suggests temporal lobe epilepsy may be linked to early aging of certain brain cells. When researchers removed these aging cells in mice, seizures dropped, memory improved, and some animals ...

The U.S. is chasing an oil tanker that refused to let members of the Coast Guard aboard in the Caribbean Sea on Saturday, Dec. 20. The move comes as President Donald Trump vows a "total and complete ...

When Derrick Henry cruised into the end zone for a 2-yard touchdown in the fourth quarter Sunday, he gave the Ravens a two-score lead and M&T Bank Stadium was rocking. The New England Patriots hadn't ...